# The Role of the Gut Metagenome on the Development of Age Related Macular Degeneration (AMD)

> **NCT02438111** · — · UNKNOWN · sponsor: **Insel Gruppe AG, University Hospital Bern** · enrollment: 1200 (estimated)

## Conditions studied

- Age Related Macular Degeneration

## Interventions

- **GENETIC:** metagenome

## Key facts

- **NCT ID:** NCT02438111
- **Lead sponsor:** Insel Gruppe AG, University Hospital Bern
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-12
- **Primary completion:** 2023-12
- **Final completion:** 2023-12
- **Target enrollment:** 1200 (ESTIMATED)
- **Last updated:** 2023-04-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02438111

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02438111, "The Role of the Gut Metagenome on the Development of Age Related Macular Degeneration (AMD)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02438111. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*